An observational, prospective and questionnaire-based study to assess awareness of pharmacovigilance among resident doctors in a tertiary healthcare centre of Bihar

Purnendu Arya, Hitesh Mishra, Manish Kumar, Adil Ali Shakur, Lalit Mohan, Harihar Dikshit

Abstract


Background: Adverse Drug Reactions (ADRs) is a global health problem requiring attention of healthcare professionals. Healthcare professionals are backbone of pharmacovigilance programme and hence have a major role for better healthcare system.

Aim: To assess the awareness of knowledge and practice of pharmacovigilance among residents in our health set-up.

Materials and Methods: An observational, prospective and questionnaire-based study comprising 15 questions pertaining to Pharmacovigilance. 60 Residents (30 junior and 30 senior residents) from different clinical departments were sampled. Questionnaire was based on two alternative answers viz "Yes" or "No". Questions were further segregated into four classes for evaluation of awareness in different spheres of pharmacovigilance. A grading scale was used to determine the awareness of residents about pharmacovigilance.

Statistical Analysis: Wilcoxon matched-pairs test using GraphPad Instat software.

Results: This study was conducted in two visits. After second visit there was significant increase in response in which education encompassing pharmacovigilance was recommended by 61.66% of residents. Percentage of residents responding “yes” regarding established independent body for reporting of ADRs was 48.33%. Further, evaluation of awareness in different spheres of pharmacovigilance showed that fundamental knowledge of pharmacovigilance among residents was excellent in 21.66%, good in 45%, average in 10% and poor in 25% of the residents.

Conclusions: Knowledge and practice of pharmacovigilance was improved among residents after giving proper sensitization. Hence, improved perception can remove the misconceptions, obstacles and barriers in practice of pharmacovigilance. Furthermore, large-scale awareness of pharmacovigilance is required among different healthcare professionals for better understanding of this system.

Keywords: Grading Scale, Knowledge, Practice, Questionnaires, Sensitization.


Full Text:

PDF

References


Ayalew MB, Megersa TN, Mengistu YT. Drug-related problems in medical wards of Tikur Anbessa specialized hospital, Ethiopia. J Res Pharm Pract. 2015;4(4):216-21.

The Importance of Pharmacovigilance Safety Monitoring of medicinal products [Internet]. United Kingdom: World Health Organization; 2002 [cited 3 April 2020]. Available from: https://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf

Aronson JK. Adverse drug reactions- no farewell to harms. Br J Clin Pharmacol. 2007;63(2):131-5.

Pirmohammed M, James S, Meakin S, Green C, Park BK. Adverse drug reactions as a cause of admission to the hospital: prospective analysis of 18820 patients. Br Med J. 2004;329:15-9.

Ratan JL, Mangala L, Sukirti D. A study on adverse drug reactions in a tertiary care hospital of northeast India. Alex J Med. 2017;53:151-6

Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;8:437-53.

Jayanthi CR, Renuka M, Panchaksharimath P. An observational Study to analyze the Adverse drug Reactions among the Elderly at A Tertiary Care Hospital. Biomed Pharmacol J. 201710(1):345-52.

Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307–11

Pharmacovigilance Programme of India (PvPI) Updates: Performance Report 2018-19 [Internet]. Ghaziabad: Indian Pharmacopoeia Commission; 2019 [cited 2 February 2020]. Available from: https://ipc.gov.in/mandates/pvpi/pvpi-updates/8-category-en/646-annual-performance-report.

Kalaiselvan V, Prakash J, Singh GN. Pharmacovigilance programme of India. Arch Pharm Pract. 2012;3:229-32.

Vallano A, Cereza G, Pedros C, Agustí A, Danés I, Aguilera C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653-8.

A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries - Springer. [cited 2020 Jan 22]; Available from: http://link.springer.com/article/10.1007/s40264-014-0143-1/fulltext.html

Hussain MM, Girhepunje K, Pal R, Siddiqua SS. Incidence of Adverse Drug Reactions in a Tertiary Care Hospital: A Systematic Review and Meta-Analysis of Prospective Studies. Scholars Res Library. 2010;2(3):358-67.

Khan FA, Nizamuddin S, Najmul H, Mishra H. A prospective study on prevalence of adverse drug reactions due to antibiotics usage in otolaryngology department of a tertiary care hospital in North India. Int J Basic Clin Pharmacol. 2013;2:548–53

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital – Their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12:687-92.

Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. J Nat Sci Biol Med. 2013;4(1):191-6.

Alan S, Ozturk M, Gokyildiz S, Avcibay B, Karatas Y. An evaluation of knowledge of pharmacovigilance among nurses and midwives in Turkey. Indian J Pharmacol. 2013;45(6):616-8.

Arias E, Schauman WS, Eschbach K, Sorlie PD, Backlund E. The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat. 2 2008;148:1-23.

Kalaiselvan V, Gakhar S, Prasad T, Gupta SK, Singh GN. Spontaneous reporting of adverse drug reactions in geriatric patients in India. Natl J Physiol Pharm Pharmacol. 2014;3:225-8.

Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Physicians’ Attitudes and Adverse Drug Reaction Reporting. Drug Saf. 2005;28(9):825-33.

Carbonin P, Bernabei R, Sgadari A. Is age an Independent risk factor of adverse drug reactions in hospitalized medical patients?. J Am Geriatr Soc. 1991;39(11):1093-9.

Gupta P, Udupa A. Adverse drug reporting and pharmacovigilance: Knowledge, attitude and perception among resident doctors. J Pharm Sci Res. 2011;3:1064-6.

Ganesan S, Vikneswaran G, Reddy KC, Subrahmanyam DK, Adithan C. A survey on knowledge, attitude and practice of pharmacovigilance towards adverse drug reactions reporting among doctors and nurses in a tertiary Care Hospital in South India. J Young Pharm. 2016;8(4):471-6.

Agarwal R, Daher AM, Ismail MN. Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from Klang valley in Malaysia. Malays J Med Sci. 2013;20(2):52-61.

Vallano A, Castañeda PF, Quijada Manuitt MA, Simon PC, Pedrós C, et al. Hospital Doctors’ Views and Concerns about Pharmacovigilance. J Pharmacovigilance. 2015;3:160.

Saini VK, Sewal RK, Ahmad Y, Medhi B. Prospective observational study of adverse drug reactions of anticancer drugs used in cancer treatment in a tertiary care hospital. Indian J Pharm Sci. 2015;77:687-93.

Grootheest V, others. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48(4):623-7.

Kharkar M, Bowalekar S. Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting. Perspect Clin Res. 2012;3;3:90-4.

Gavaza P, Brown CM, Khoza S. Texas pharmacists‟ opinions on reporting serious adverse drug events to the Food and Drug Administration: a qualitative study. Pharm World Sci. 2010;32(5):651-7.

Fabbri S, Sichetti D, Di Giulio P. Efficacy of an education on adverse drug reaction reporting by nurses in nursing homes: A pre-post study. J Hosp Clin Pharm. 2016;2(3):6-13.